Literature DB >> 16681635

Eosinophilia: secondary, clonal and idiopathic.

Ayalew Tefferi1, Mrinal M Patnaik, Animesh Pardanani.   

Abstract

Blood eosinophilia signifies either a cytokine-mediated reactive phenomenon (secondary) or an integral phenotype of an underlying haematological neoplasm (primary). Secondary eosinophilia is usually associated with parasitosis in Third World countries and allergic conditions in the West. Primary eosinophilia is operationally classified as being clonal or idiopathic, depending on the respective presence or absence of a molecular, cytogenetic or histological evidence for a myeloid malignancy. The current communication features a comprehensive clinical summary of both secondary and primary eosinophilic disorders with emphasis on recent developments in molecular pathogenesis and treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16681635     DOI: 10.1111/j.1365-2141.2006.06038.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  63 in total

1.  A young man with persistent eosinophilia.

Authors:  E Messa; D Cilloni; G Saglio
Journal:  Intern Emerg Med       Date:  2007-06       Impact factor: 3.397

Review 2.  Eosinophilic Vasculitis.

Authors:  Karen L Vega Villanueva; Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2020-01-11       Impact factor: 4.592

Review 3.  Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field.

Authors:  Peter Valent; Gerald J Gleich; Andreas Reiter; Florence Roufosse; Peter F Weller; Andrzej Hellmann; Georgia Metzgeroth; Kristin M Leiferman; Michel Arock; Karl Sotlar; Joseph H Butterfield; Sabine Cerny-Reiterer; Matthias Mayerhofer; Peter Vandenberghe; Torsten Haferlach; Bruce S Bochner; Jason Gotlib; Hans-Peter Horny; Hans-Uwe Simon; Amy D Klion
Journal:  Expert Rev Hematol       Date:  2012-04       Impact factor: 2.929

4.  Loeffler endocarditis: silent right ventricular myocardium!

Authors:  Süha Çetin; Gülümser Heper; Mustafa Gökhan Vural; Tuncay Hazirolan
Journal:  Wien Klin Wochenschr       Date:  2016-03-15       Impact factor: 1.704

Review 5.  Paraneoplastic syndromes: an approach to diagnosis and treatment.

Authors:  Lorraine C Pelosof; David E Gerber
Journal:  Mayo Clin Proc       Date:  2010-09       Impact factor: 7.616

Review 6.  Primary eosinophilic disorders: a concise review.

Authors:  Animesh Pardanani; Ayalew Tefferi
Journal:  Curr Hematol Malig Rep       Date:  2008-01       Impact factor: 3.952

7.  The coincidence of familial mediterranean Fever and hypereosinophilia in a patient with hereditary elliptocytosis.

Authors:  Muzaffer Keklik; Ali Unal; Serdar Sivgin; Olgun Kontas; Eray Eroglu; Semih Yilmaz; Leylagul Kaynar; Bulent Eser; Mustafa Cetin
Journal:  Indian J Hematol Blood Transfus       Date:  2013-08-27       Impact factor: 0.900

Review 8.  Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update.

Authors:  Ayalew Tefferi; Jason Gotlib; Animesh Pardanani
Journal:  Mayo Clin Proc       Date:  2010-01-06       Impact factor: 7.616

9.  Pregnancy in a patient with hypereosinophilic syndrome.

Authors:  Patricia Ault; Jorge Cortes; Alice Lynn; Michael Keating; Srdan Verstovsek
Journal:  Leuk Res       Date:  2008-07-01       Impact factor: 3.156

10.  Drug-induced hematologic syndromes.

Authors:  David M Mintzer; Shira N Billet; Lauren Chmielewski
Journal:  Adv Hematol       Date:  2009-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.